Veterinary Medicines

NOBILIS MA 5 + CLONE 30

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
Download as PDF

Product identification

Medicine name:
NOBILIS MA 5 + CLONE 30
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
Target species:
  • Chicken (one day-old chick)
Route of administration:
  • Nebulisation use
  • Oral use
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    3.00
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)
  • Newcastle disease virus, strain Clone 30, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0323807 5/2000
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."